Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Incorporated in 1992, is engaged in the purchase, sale and distribution of various pharmaceutical, medical and medicinal products.
The company develops, manufactures, distributes and supplies chemicals used in the production of pharmaceuticals, drug enzymes and sanitary napkins.
The company has entered into a partnership with Abbott Point of Care Corporation Inc. based in the USA to distribute their specialized diagnostic device, the i-STAT 1 Analyzer. This device is used exclusively in intensive care units and hospital ICCUs for immediate test results. The i-STAT 1 Analyzer is lightweight, portable and easy to use. It utilizes the advanced technology of the i-STAT test cassettes. Together they form the i-STAT system - a point-of-care testing platform that provides healthcare professionals with diagnostic information at the time and place it is needed.
| Issue Open | January 23, 2024 - February 13, 2024 |
| Security Name | Genpharmasec Limited |
| Issue Size (Shares) | 276,859,850 |
| Issue Size (Amount) | ₹48.45 Crores |
| Issue Price | ₹1.75 per share |
| Face Value | ₹1 per share |
| Listing At | BSE |
| Terms of Payment | Full amount of Rs.1.75 per Equity Share is payable on application. |
| Entitlement | 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date |
| Last Date to buy shares | January 8, 2024 |
| Record Date | January 9, 2024 |
| Credit of Rights Entitlements | |
| Bid/Offer Opens On | January 23, 2024 |
| Renunciation of Rights Entitlements | February 2, 2024 |
| Bid/Offer Closes On | February 13, 2024 |
| Deemed Date of Allotment | February 16, 2024 |
| Credit Date | February 21, 2024 |
| Listing Date | February 26, 2024 |
Genpharmasec Limited's revenue decreased by -6.56% and profit after tax (PAT) rose by 637.15% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 19.88 | 21.65 | 27.82 |
| Revenue | 25.62 | 27.41 | 21.64 |
| Profit After Tax | 1.12 | -0.21 | 1.26 |
| Net Worth | 29.91 | 28.78 | 28.99 |
| Reserves and Surplus | 28.78 | 28.99 | |
| Total Borrowing | 3.08 | ||
| Amount in ₹ Crore | |||
The company proposes to utilize the net proceeds from the Issue towards funding the following objects:
Genpharmasec Rights Issue 2024 got oversubscribed by 1.5 times by the end of the bidding period with total bid quantity received by BSE of 414,741,563 shares.
29 3.9 Rating:  Vote Here ... |
Genpharmasec Limited
Office No. 104 & 105 (1st Floor),
Gundecha Industrial Premises, Co-Op Society Ltd
Akurli Road, Kandivali (East), Mumbai,- 400101
Phone: +91- 86555 50242
Email: info@genpharmasec.com
Website: https://www.genpharmasec.com/
Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: newissue@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query
The Genpharmasec Rights Issue 2024 opens on January 23, 2024, and closes on February 13, 2024.
Genpharmasec Rights Issue 2024 Schedule
| Last Date for credit of Rights Entitlements | |
| Last Date for renunciation of Rights Entitlements | February 2, 2024 |
| Issue Opening Date | January 23, 2024 |
| Issue Closing Date | February 13, 2024 |
| Date of Allotment (on or about) | February 16, 2024 |
| Date of Credit (on or about) | February 21, 2024 |
| Date of Listing (on or about) | February 26, 2024 |
Genpharmasec Rights Issue 2024 price is set at ₹1.75 per share per equity share.
The eligible shareholders are being offered 1 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date (January 9, 2024).
The record date for the Genpharmasec Rights Issue 2024 is January 9, 2024.
The issue size of Genpharmasec Rights Issue 2024 is of 276,859,850 equity shares at ₹1.75 per share aggregating upto ₹48.45 Crores.
The Letter of Offer for Genpharmasec Rights Issue 2024 can be download here.
You can apply for Genpharmasec Rights Issue 2024 in two ways:
Steps to apply for Genpharmasec Rights Issue 2024 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Genpharmasec Rights Issue 2024 using Registrar's website (R-WAP)
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
